CLINICAL_TRIALS trial_result · 2019-10-30

Clinical Trial Update: Dose-ranging Study in Patients With Type 1 Diabetes Mellitus [Phase 2]

A Phase 2 dose-ranging study in patients with Type 1 Diabetes Mellitus has completed; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2019-10-30